Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 92

1.

Human memory T cell responses to SARS-CoV E protein.

Peng H, Yang LT, Li J, Lu ZQ, Wang LY, Koup RA, Bailer RT, Wu CY.

Microbes Infect. 2006 Aug;8(9-10):2424-31. Epub 2006 Jun 30.

PMID:
16844400
2.

Long-lived memory T lymphocyte responses against SARS coronavirus nucleocapsid protein in SARS-recovered patients.

Peng H, Yang LT, Wang LY, Li J, Huang J, Lu ZQ, Koup RA, Bailer RT, Wu CY.

Virology. 2006 Aug 1;351(2):466-75. Epub 2006 May 11.

3.

Priming with SARS CoV S DNA and boosting with SARS CoV S epitopes specific for CD4+ and CD8+ T cells promote cellular immune responses.

Huang J, Cao Y, Du J, Bu X, Ma R, Wu C.

Vaccine. 2007 Sep 28;25(39-40):6981-91. Epub 2007 Jul 16.

PMID:
17709158
4.

Persistent memory CD4+ and CD8+ T-cell responses in recovered severe acute respiratory syndrome (SARS) patients to SARS coronavirus M antigen.

Yang L, Peng H, Zhu Z, Li G, Huang Z, Zhao Z, Koup RA, Bailer RT, Wu C.

J Gen Virol. 2007 Oct;88(Pt 10):2740-8.

5.

Long-lived effector/central memory T-cell responses to severe acute respiratory syndrome coronavirus (SARS-CoV) S antigen in recovered SARS patients.

Yang LT, Peng H, Zhu ZL, Li G, Huang ZT, Zhao ZX, Koup RA, Bailer RT, Wu CY.

Clin Immunol. 2006 Aug;120(2):171-8. Epub 2006 Jun 16.

PMID:
16781892
6.

Virus-specific memory CD8 T cells provide substantial protection from lethal severe acute respiratory syndrome coronavirus infection.

Channappanavar R, Fett C, Zhao J, Meyerholz DK, Perlman S.

J Virol. 2014 Oct;88(19):11034-44. doi: 10.1128/JVI.01505-14. Epub 2014 Jul 23.

7.

Characterization of SARS-CoV-specific memory T cells from recovered individuals 4 years after infection.

Fan YY, Huang ZT, Li L, Wu MH, Yu T, Koup RA, Bailer RT, Wu CY.

Arch Virol. 2009;154(7):1093-9. doi: 10.1007/s00705-009-0409-6. Epub 2009 Jun 13.

8.

Response of memory CD8+ T cells to severe acute respiratory syndrome (SARS) coronavirus in recovered SARS patients and healthy individuals.

Chen H, Hou J, Jiang X, Ma S, Meng M, Wang B, Zhang M, Zhang M, Tang X, Zhang F, Wan T, Li N, Yu Y, Hu H, Yang R, He W, Wang X, Cao X.

J Immunol. 2005 Jul 1;175(1):591-8.

9.

CD8+ T cell response in HLA-A*0201 transgenic mice is elicited by epitopes from SARS-CoV S protein.

Zhao K, Yang B, Xu Y, Wu C.

Vaccine. 2010 Sep 24;28(41):6666-74. doi: 10.1016/j.vaccine.2010.08.013. Epub 2010 Aug 13.

PMID:
20709007
10.

T-cell epitopes in severe acute respiratory syndrome (SARS) coronavirus spike protein elicit a specific T-cell immune response in patients who recover from SARS.

Wang YD, Sin WY, Xu GB, Yang HH, Wong TY, Pang XW, He XY, Zhang HG, Ng JN, Cheng CS, Yu J, Meng L, Yang RF, Lai ST, Guo ZH, Xie Y, Chen WF.

J Virol. 2004 Jun;78(11):5612-8. Erratum in: J Virol. 2004 Jul;78(14):7861. Yang Huang-Hua [corrected to Yang Huang-Hao].

11.

Immunization with SARS-CoV S DNA vaccine generates memory CD4+ and CD8+ T cell immune responses.

Huang J, Ma R, Wu CY.

Vaccine. 2006 Jun 5;24(23):4905-13. Epub 2006 Apr 4.

PMID:
16621188
12.

Immunological characterizations of the nucleocapsid protein based SARS vaccine candidates.

Liu SJ, Leng CH, Lien SP, Chi HY, Huang CY, Lin CL, Lian WC, Chen CJ, Hsieh SL, Chong P.

Vaccine. 2006 Apr 12;24(16):3100-8. Epub 2006 Feb 8.

PMID:
16494977
13.

T cell responses to whole SARS coronavirus in humans.

Li CK, Wu H, Yan H, Ma S, Wang L, Zhang M, Tang X, Temperton NJ, Weiss RA, Brenchley JM, Douek DC, Mongkolsapaya J, Tran BH, Lin CL, Screaton GR, Hou JL, McMichael AJ, Xu XN.

J Immunol. 2008 Oct 15;181(8):5490-500.

14.

Priming with rAAV encoding RBD of SARS-CoV S protein and boosting with RBD-specific peptides for T cell epitopes elevated humoral and cellular immune responses against SARS-CoV infection.

Du L, Zhao G, Lin Y, Chan C, He Y, Jiang S, Wu C, Jin DY, Yuen KY, Zhou Y, Zheng BJ.

Vaccine. 2008 Mar 20;26(13):1644-51. doi: 10.1016/j.vaccine.2008.01.025. Epub 2008 Feb 4.

15.

Engineering T cells specific for a dominant severe acute respiratory syndrome coronavirus CD8 T cell epitope.

Oh HL, Chia A, Chang CX, Leong HN, Ling KL, Grotenbreg GM, Gehring AJ, Tan YJ, Bertoletti A.

J Virol. 2011 Oct;85(20):10464-71. doi: 10.1128/JVI.05039-11. Epub 2011 Aug 3.

16.

HLA-A*0201 T-cell epitopes in severe acute respiratory syndrome (SARS) coronavirus nucleocapsid and spike proteins.

Tsao YP, Lin JY, Jan JT, Leng CH, Chu CC, Yang YC, Chen SL.

Biochem Biophys Res Commun. 2006 May 26;344(1):63-71.

PMID:
16630549
17.

Identification of an HLA-A*0201-restricted CD8+ T-cell epitope SSp-1 of SARS-CoV spike protein.

Wang B, Chen H, Jiang X, Zhang M, Wan T, Li N, Zhou X, Wu Y, Yang F, Yu Y, Wang X, Yang R, Cao X.

Blood. 2004 Jul 1;104(1):200-6. Epub 2004 Mar 11.

18.

Searching immunodominant epitopes prior to epidemic: HLA class II-restricted SARS-CoV spike protein epitopes in unexposed individuals.

Yang J, James E, Roti M, Huston L, Gebe JA, Kwok WW.

Int Immunol. 2009 Jan;21(1):63-71. doi: 10.1093/intimm/dxn124. Epub 2008 Dec 2.

19.

Identification of murine CD8 T cell epitopes in codon-optimized SARS-associated coronavirus spike protein.

Zhi Y, Kobinger GP, Jordan H, Suchma K, Weiss SR, Shen H, Schumer G, Gao G, Boyer JL, Crystal RG, Wilson JM.

Virology. 2005 Apr 25;335(1):34-45.

20.

SARS Immunity and Vaccination.

Zhu M.

Cell Mol Immunol. 2004 Jun;1(3):193-8. Review.

Supplemental Content

Support Center